127 related articles for article (PubMed ID: 9827943)
1. Hydroxyurea treatment in thalassaemia.
Konstantopoulos K; Lymperi S
Br J Haematol; 1998 Nov; 103(2):587. PubMed ID: 9827943
[No Abstract] [Full Text] [Related]
2. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia.
Saxon BR; Rees D; Olivieri NF
Br J Haematol; 1998 Jun; 101(3):416-9. PubMed ID: 9633880
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports.
Karimi M; Cohan N; Pishdad P
Hematology; 2015 Jan; 20(1):53-7. PubMed ID: 24717020
[TBL] [Abstract][Full Text] [Related]
4. A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea?
Konstantopoulos K; Vagiopoulos G; Kantouni R; Lymperi S; Patriarcheas G; Georgakopoulos D; Fessas P
Haematologica; 1992; 77(4):352-4. PubMed ID: 1385278
[TBL] [Abstract][Full Text] [Related]
5. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
6. The activity of superoxide dismutase in hydroxyurea-treated E beta thalassemia.
Ajanta H; Chakraborty S; Madhusnata D; Bhattacharya DK; Manisha D
J Assoc Physicians India; 2002 Aug; 50():1034-5. PubMed ID: 12421025
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review.
Meo A; Cassinerio E; Castelli R; Bignamini D; Perego L; Cappellini MD
Int J Lab Hematol; 2008 Oct; 30(5):425-31. PubMed ID: 19046318
[TBL] [Abstract][Full Text] [Related]
8. Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients.
Rigano P; Pecoraro A; Calzolari R; Troia A; Acuto S; Renda D; Pantalone GR; Maggio A; Di Marzo R
Br J Haematol; 2010 Dec; 151(5):509-15. PubMed ID: 20955403
[TBL] [Abstract][Full Text] [Related]
9. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
Cario H; Wegener M; Debatin KM; Kohne E
Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
[TBL] [Abstract][Full Text] [Related]
10. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP;
Br J Haematol; 2005 Nov; 131(3):378-88. PubMed ID: 16225658
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea therapy in paraparesis and cauda equina syndrome due to extramedullary haematopoiesis in thalassaemia: improvement of clinical and haematological parameters.
Cianciulli P; di Toritto TC; Sorrentino F; Sergiacomi L; Massa A; Amadori S
Eur J Haematol; 2000 Jun; 64(6):426-9. PubMed ID: 10901597
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatment of thalassemia intermedia with hydroxyurea.
Hajjar FM; Pearson HA
J Pediatr; 1994 Sep; 125(3):490-2. PubMed ID: 7520935
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia.
Aessopos A; Tassiopoulos S; Farmakis D; Moyssakis I; Kati M; Polonifi K; Tsironi M
Ann Thorac Surg; 2006 Jun; 81(6):2037-43. PubMed ID: 16731126
[TBL] [Abstract][Full Text] [Related]
14. Extramedullary hematopoiesis with spinal cord compression in a child with thalassemia intermedia.
Ileri T; Azik F; Ertem M; Uysal Z; Gozdasoglu S
J Pediatr Hematol Oncol; 2009 Sep; 31(9):681-3. PubMed ID: 19687759
[TBL] [Abstract][Full Text] [Related]
15. A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.
Yasara N; Wickramarathne N; Mettananda C; Silva I; Hameed N; Attanayaka K; Rodrigo R; Wickramasinghe N; Perera L; Manamperi A; Premawardhena A; Mettananda S
Sci Rep; 2022 Feb; 12(1):2752. PubMed ID: 35177777
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Olivieri NF
Semin Hematol; 1996 Jan; 33(1):24-42. PubMed ID: 8714583
[No Abstract] [Full Text] [Related]
17. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/beta-thalassaemia.
Voskaridou E; Kalotychou V; Loukopoulos D
Br J Haematol; 1995 Mar; 89(3):479-84. PubMed ID: 7537527
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea therapy in highly unstable hemoglobin carriers.
Rose C; Bauters F; Galacteros F
Blood; 1996 Oct; 88(7):2807-8. PubMed ID: 8839880
[No Abstract] [Full Text] [Related]
20. DNA hypomethylation therapies and hemoglobin disorders. [An interview with Hassana Fathallah by H&O].
Fathallah H
Clin Adv Hematol Oncol; 2008 Nov; 6(11):806-8. PubMed ID: 19194363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
